证券代码：300677 证券简称：英科医疗 公告编号：2025-122 英科医疗科技股份有限公司 关于为子公司提供担保事项的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 英科医疗科技股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日、2025 年 5 月 26 日分别召开的第四届董事会第二次（定期） 会议、第四届监事会第二次（定期）会议以及 2024 年度股东大会， 审议通过了《关于公司及子公司向银行申请授信额度及担保事项的议 案》。为满足公司及子公司的生产经营需要，公司及子公司拟向银行 等金融机构申请综合授信的额度以及金融衍生品交易风险限额的总 额（以下简称"授信额度"）不超过 360 亿元人民币，对其担保总额 不超过 360 亿元人民币，授权期限自公司 2024 年度股东大会审议通 过之日起至下一年度股东大会召开时止。具体内容详见刊登于巨潮资 讯网（www.cninfo.com.cn）的《关于公司及子公司向银行申请授信额 度及担保事项的公告》《2024 年度股东大会决议公告》（公告编号： 2025-046、2025-072）。 一、担 ...

每经头条（nbdtoutiao）——申请超2万份，已开出41家，加盟海底捞，你要准备多少钱？1000万元不算 多，真实"账单"公布 （记者 张喜威） 每经AI快讯，英科医疗（SZ 300677，收盘价：37.65元）8月29日发布公告称，公司第四届第八次董事 会会议于2025年8月28日在公司会议室以现场会议结合通讯方式召开。会议审议了《关于<2025年半年 度报告>及其摘要的议案》等文件。 2024年1至12月份，英科医疗的营业收入构成为：医疗器械占比100.0%。 ...

Group 1 - The core viewpoint of the article highlights the financial performance of Yingke Medical, reporting a revenue increase and profit growth for the first half of 2025 [1] Group 2 - Yingke Medical's revenue for the first half of 2025 is approximately 4.913 billion yuan, representing an 8.9% year-on-year increase [1] - The net profit attributable to shareholders is around 710 million yuan, showing a year-on-year increase of 21.02% [1] - The basic earnings per share is 1.12 yuan, which is a 24.44% increase compared to the previous year [1]

Core Viewpoint - In the first half of 2025, Yingke Medical (300677.SZ) reported a revenue of 4.913 billion yuan, reflecting a year-on-year growth of 8.90% and a net profit attributable to shareholders of 710 million yuan, which is a 21.02% increase [1] Financial Performance - The company's operating revenue reached 4.913 billion yuan, marking an 8.90% increase compared to the previous year [1] - The net profit attributable to shareholders was 710 million yuan, showing a year-on-year growth of 21.02% [1] - The net profit after deducting non-recurring gains and losses was 400 million yuan, which represents a decrease of 17.79% year-on-year [1] - Basic earnings per share stood at 1.12 yuan [1] Product Category Performance - Revenue from personal protective products was 4.494 billion yuan, reflecting a year-on-year increase of 9.31% [1] - Revenue from rehabilitation and nursing products was 234 million yuan, showing a slight growth of 0.40% year-on-year [1] - Revenue from other products amounted to 185 million yuan, which is a year-on-year increase of 10.41% [1]

Core Viewpoint - In the first half of 2025, the company reported a revenue of 4.913 billion yuan, reflecting a year-on-year growth of 8.90% [1] - The net profit attributable to shareholders reached 710 million yuan, marking a year-on-year increase of 21.02% [1] - The basic earnings per share were 1.12 yuan, and the company proposed a cash dividend of 0.5 yuan per 10 shares (tax included) [1] Financial Performance - Revenue for the first half of 2025: 4.913 billion yuan, up 8.90% year-on-year [1] - Net profit attributable to shareholders: 710 million yuan, up 21.02% year-on-year [1] - Basic earnings per share: 1.12 yuan [1] Dividend Proposal - Proposed cash dividend: 0.5 yuan per 10 shares (including tax) [1]

证券日报网讯 8月28日晚间，英科医疗发布公告称，公司第四届董事会第八次（定期）会议审议通过了 《关于及其摘要的议案》等。 （文章来源：证券日报） ...

Core Viewpoint - In the first half of 2025, the company Inco Medical achieved significant revenue growth despite challenges from international situations and tariffs, with a revenue of 4.913 billion yuan, up 8.9% year-on-year, and a net profit of 710 million yuan, up 21.02% year-on-year [1] Group 1: Industry Overview - The global disposable glove industry has undergone significant changes, with Malaysia dominating the supply before 2019, followed by accelerated production expansion by Chinese companies from 2020 to 2021, leading to a shift in competitive dynamics [1] - The industry faced severe competition and price drops to historical lows from 2022 to 2023 due to supply-demand imbalances, but signs of recovery and improved capacity utilization were noted in 2024 [1] Group 2: Company Performance - In the first half of 2025, the company maintained full production and sales while significantly increasing its development efforts in non-U.S. markets, resulting in a 45% year-on-year increase in overseas non-U.S. market sales and a 35% increase in domestic market sales [1] - The company has established a leading global manufacturing capability with an annual production capacity of 87 billion gloves, including 56 billion nitrile gloves and 31 billion PVC gloves, supported by advanced automated production lines and intelligent control systems [2] Group 3: Future Initiatives - The company is steadily advancing the construction of overseas production bases, enhancing its global supply chain layout to support business globalization [2] - In terms of green development, the company initiated a wind power project in Anhui in 2024, aiming for completion and operation in 2025, which will increase the share of clean energy in its overall energy structure [2] - The company plans to integrate green energy with medical production to promote sustainable development in the industry [2]

英科医疗科技股份有限公司 2025 年半年度非经营性资金占用及其他关联资金往来情况汇总表 单位： 人民币万元 | 非经营性资金占用 | 资金占 用方名 | 占用方与上市 公司的关联关 | 上市公司核 算的会计科 | 年期初占 2025 | 2025 | 上半年占用累计 发生金额（不含利 | 上半年偿还 2025 | 上半年占 2025 | 占用形成 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 用资金余额 | | | 累计发生金额 | 用资金余额 | 原因 | | | | 称 | 系 | 目 | | | 息） | | | | | | 控股股东、实际控 制人及其附属企业 | | | | | | 不适用 | | | | | | 小 计 | | | | | | 不适用 | | | | | | 前控股股东、实际 控制人及其附属企 | | | | | | 不适用 | | | | | | 业 | | | | | | | | | | | | 小 计 | | | | | | 不适用 | | | | ...

证券代码：300677 证券简称：英科医疗 公告编号：2025-119 英科医疗科技股份有限公司 为使投资者全面了解报告期内公司的经营情况和财务状况，公司 《2025 年半年度报告》全文及摘要将于 2025 年 8 月 29 日在巨潮资 讯网（www.cninfo.com.cn）披露，敬请投资者注意查阅。 特此公告。 英科医疗科技股份有限公司 董 事 会 2025 年 8 月 29 日 2025 年半年度报告披露提示性公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 英科医疗科技股份有限公司（以下简称"公司"）于 2025 年 8 月 28 日召开第四届董事会第八次（定期）会议，审议通过了《关于 <2025 年半年度报告>及其摘要的议案》。该议案已经公司第四届董事 会审计委员会第五次会议审议通过。 ...

报告显示，上半年实现营业收入49.13亿元，同比增长8.9%；归属股东净利润7.1亿元，同比增长 21.02%。 公司是一家立足中国的综合型医疗护理产品供应商，主营业务涵盖个人防护、康复护理、其他产品三大 板块，主要产品包括一次性手套、轮椅、冷热敷、电极片等多种类型的护理产品，产品广泛应用于医疗 机构、养老护理机构、日用消费及其他相关行业。 公司康复护理产品属于康复护理行业里辅助行走的产品类型，包括电动轮椅车、手动轮椅车、助行器、 助步器、手杖及医用床边桌，是肢体伤残者、老年人和行动不便人士的代步工具，用于辅助行走、住院 的医疗护理及残疾人士的日常护理。 8月28日晚间，英科医疗发布2025年半年度报告。 ...